Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study.

Chang, Hui-Min; Chou, Pei-Yun; Chou, Chen-Hsi; Tsai, Hung-Chin

Chang, Hui-Min; Chou, Pei-Yun; Chou, Chen-Hsi; Tsai, Hung-Chin.

Afiliação

Chang HM; Department of Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Chou PY; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Chou CH; Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, Pingtung, Taiwan.
Tsai HC; Section of Infectious Diseases, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Infect Drug Resist ; 14: 4877-4886, 2021.

Article em En | MEDLINE | ID: mdl-34853517

Palavras-chave

Biktarvy; bictegravir; switching; viremia; virological failure

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Infect Drug Resist Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google